Targeted intestinal delivery of incretin secretagogues-towards new diabetes and obesity therapies. (2018)
Attributed to:
Enabling technologies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.peptides.2017.11.008
PubMed Identifier: 29412834
Publication URI: http://europepmc.org/abstract/MED/29412834
Type: Journal Article/Review
Volume: 100
Parent Publication: Peptides
ISSN: 0196-9781